0001125345-24-000018.txt : 20240212
0001125345-24-000018.hdr.sgml : 20240212
20240212173137
ACCESSION NUMBER: 0001125345-24-000018
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240208
FILED AS OF DATE: 20240212
DATE AS OF CHANGE: 20240212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Karrels James
CENTRAL INDEX KEY: 0001587477
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36112
FILM NUMBER: 24621509
MAIL ADDRESS:
STREET 1: 9640 MEDICAL CENTER DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MACROGENICS INC
CENTRAL INDEX KEY: 0001125345
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9704 MEDICAL CENTER DRIVE
CITY: Rockville
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-251-5172
MAIL ADDRESS:
STREET 1: 9704 MEDICAL CENTER DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
4
1
wk-form4_1707777084.xml
FORM 4
X0508
4
2024-02-08
0
0001125345
MACROGENICS INC
MGNX
0001587477
Karrels James
9704 MEDICAL CENTER DRIVE
ROCKVILLE
MD
20850
0
1
0
0
SVP, CFO and Secretary
0
Employee Stock Option (right to buy)
18.30
2024-02-08
4
A
0
80000
0
A
2034-02-08
Common Stock
80000
80000
D
Restricted Stock Unit
2024-02-08
4
A
0
30000
0
A
Common Stock
30000
30000
D
12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.
Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.
The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.
/s/ Lynn M. Cilinski, Attorney-in-fact
2024-02-12